KCE Trials

Check out this nice funding opportunity from the Health Data Agency ! If you have a good research idea based on existing health care data (=secondary use), this is the place to apply for some funding. It's good to see such an initiative coming to Belgium !

KCE Trials would like to congratulate CI Prof C Rosmans, National Coordinator Dr H Van Veer and his team at UZ Leuven on randomising the first participant in the PERSuaDER study: PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy (BeNeFIT21563). This study aims to show whether selective decontamination of the digestive tract with antibiotics before and immediately after surgery, for esophageal cancer, gives better outcomes, specifically less postoperative pneumonia. The study will include 853 participants in 18-19 sites, 6-7 of which are in Belgium.   More info on the study on the KCE website: https://lnkd.in/eNmtqEju   #KCETrials #publicfunder #ClinicalResearch #BeNeFIT ZonMw

KCE Trials is delighted to announce the funding of the HIT Hard study: A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dose and Duration in critically ill patients (BeNeFIT-220010). This study seeks to determine whether a shorter course of high dose antibiotics is not less effective than the standard longer course with the aim of contributing to good antibiotic stewardship.  Congratulations to the Sponsor UZ Gent, CI Prof. Dr. Jan De Waele and Dutch Coordinating Centre Radboud University Medical Centre. The study will recruit in 14 sites, 7 of which are in Belgium.   More info on the study on the KCE website: https://lnkd.in/e-48N6TZ   #KCETrials #ClinicalTrials #BeNeFIT ZonMw #AMR

📣 Call open 📣 ZonMw and KCE Trials are joining forces again to fund collaborative research that will improve health outcomes for patients in Belgium and the Netherlands. - 9.2 million € for non-commercial pragmatic RCTs. online info session on November 5th All info on KCE website: https://lnkd.in/eGgGBWT8 #KCETrials hashtag #publicfunder hashtag #clinicalresearch hashtag #impact

📣 Call open 📣 ZonMw and KCE Trials are joining forces again to fund collaborative research that will improve health outcomes for patients in Belgium and the Netherlands. - 9.2 million € for non-commercial pragmatic RCTs. online info session on November 5th All info on KCE website: https://lnkd.in/eGgGBWT8 #KCETrials hashtag #publicfunder hashtag #clinicalresearch hashtag #impact

🚀 New Release Alert! 🚀 We are pleased to announce the release of our latest infographic, “KCE Trials in a Nutshell 2024”! 🔍 What KCE Trials Does: KCE Trials focuses on funding pragmatic comparative effectiveness research, which aims to determine the best treatments in real-world settings. These trials are non-commercial and emphasize data sharing to maximize the impact of their findings. By supporting high-quality, investigator-led clinical trials, KCE Trials helps improve healthcare practices and patient outcomes. 🔍 Key Highlights: - Focus on pragmatic comparative effectiveness, non-commercial trials, and data sharing. Drug repurposing trials are also in scope under certain conditions. - A €10 million annual budget dedicated to funding of studies. - Enhanced quality support with training for trial teams and extended audits. - Funding of national trials and participation to international studies. Collaboration with ZonMw to fund studies in Belgium-Netherlands. - 41 trials ongoing, over 30,000 participants recruited, and 15 trials completed. -75 peer-reviewed publications We invite you to explore the infographic and learn more about our commitment to advancing healthcare through impactful clinical trials. 📊 Check it out now! #KCETrials #PublicFunder #ClinicalTrials #Infographic

Join us for Trials Symposium on Thursday 28th Nov in Brussels ! Good speakers, brilliant topics, and a lot of opportunities to meet interesting people ! Accreditation in "Ethics and Health Economics" has been asked. Symposium is free but you need to register. All info here: https://lnkd.in/gwKFiguX #KCETrials #publicfunder #clinicalresearch #letsmeet!

KCE Trials is happy to announce the funding of the TELSTAR-2 study: Evaluation of treatment with anti-seizure medication in comatose cardiac arrest patients with status epilepticus on continuous electroencephalographic (BeNeFIT-221002). This study seeks to determine whether adding a treatment for definitive seizure suppression, in addition to standard of care, improves functional recovery for adult comatose patients after out of hospital cardiac arrest and successful cardiopulmonary resuscitation, admitted to the intensive care unit, with ESE on continuous EEG. Congratulations to the Sponsor University of Twente, CI Prof. J. Hofmeijer, Belgian National Coordinator Nicolas Gaspard and coordinating centre Hôpital Universitaire de Bruxelles (H.U.B) - Academisch Ziekenhuis Brussel (H.U.B). The study will recruit in 21 sites, 8 of which are in Belgium. More info on the study on the KCE website: https://lnkd.in/eqXS3GDa   #KCETrials #ClinicalTrials #BeNeFIT ZonMw

🎉 500 Followers! 🎉 We are excited to announce that KCE Trials has reached 500 followers here on LinkedIn! 🙌 A big thank you to this community for your continued support and interest in our work. At KCE Trials, our mission is to support non-commercial clinical research that benefits patients in Belgium and beyond. Your engagement fuels our drive to ensure that independent research continues to thrive. Every follow, like, and comment helps spread the word about the importance of high-quality, transparent clinical trials that put patients first. We look forward to sharing more updates, research breakthroughs, and funding opportunities with you. Let’s keep working together for better health! 🔬💙 Thank you again from the entire KCE Trials team 💙🔬 #KCETrials #PublicFunder #ClinicalResearch #IndependentResearch

KCE has published a new annual report covering all 2023 activities. Have a look of you want to know more!